Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Boston Scientifc (BSX) Crosses Pivot Point Resistance at $42.82

Shares of Boston Scientifc (NYSE:BSX) opened today above their pivot of $42.58 and have already reached the first level of resistance at $42.82. Analysts will be watching for a cross of the next upside...

BSX : 41.17 (-3.56%)
Global Catheters Market Outlook to 2023 with Profiles on Abbott Laboratories, Boston Scientific, Hollister, Medtronic, Stryker, and More

The "Global Markets for Catheters" report has been added to ResearchAndMarkets.com's offering.

BSX : 41.17 (-3.56%)
Global Markets for Catheters, 2017-2018 & 2019-2023 - ResearchAndMarkets.com

The "Global Markets for Catheters" report has been added to ResearchAndMarkets.com's offering.

ABT : 81.93 (-2.89%)
BSX : 41.17 (-3.56%)
Global Neurostimulation Devices Market Forecast (2019-2026) Featuring Key Players Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, and Nevro - ResearchAndMarkets.com

The "Neurostimulation Devices Market Size, Share & Trends Analysis Report By Application (Pain Management, Urinary & Fecal Incontinence, Epilepsy), By Product (Spinal Cord, Deep Brain Stimulators), And...

BSX : 41.17 (-3.56%)
STJ : 80.82 (+0.16%)
MDT : 106.05 (-1.65%)
BAX vs. BSX: Which Stock Is the Better Value Option?

BAX vs. BSX: Which Stock Is the Better Value Option?

BSX : 41.17 (-3.56%)
BAX : 85.03 (-2.50%)
Boston Scientific to Participate in the 2019 Wells Fargo Securities Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2019 Wells Fargo Securities Healthcare Conference on Thursday, September 5, 2019 in Boston.

WFC : 44.42 (-2.63%)
BSX : 41.17 (-3.56%)
Boston Scientific's (BSX) Vercise Gevia DBS Gets FDA Nod

Boston Scientific's (BSX) Vercise Gevia DBS system should boost neuromodulation revenues for the company.

EYE : 26.93 (-6.30%)
BSX : 41.17 (-3.56%)
LMAT : 31.05 (-1.27%)
CAPR : 2.59 (-4.43%)
Here's Why You Should Hold Varian Medical (VAR) Stock Now

Varian (VAR) raises the revenue guidance for fiscal 2019.

VAR : 106.12 (-1.96%)
BSX : 41.17 (-3.56%)
BAX : 85.03 (-2.50%)
XRAY : 51.67 (-2.42%)
Boston Scientific Announces FDA Approval Of ImageReady(TM) MRI For Vercise Gevia(TM) Deep Brain Stimulation System

Boston Scientific Corporation (NYSE:BSX) announced the U.S. Food and Drug Administration (FDA) approval of its ImageReady(TM) MRI labeling for the Vercise Gevia(TM) Deep Brain Stimulation (DBS) System...

BSX : 41.17 (-3.56%)
Boston Scientific Closes Acquisition of BTG plc.

Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes...

BTG : 3.52 (+2.92%)
BSX : 41.17 (-3.56%)
Teledyne Technologies, Netgear, Boston Scientific, Medtronic and Becton Dickinson highlighted as Zacks Bull and Bear of the Day

Teledyne Technologies, Netgear, Boston Scientific, Medtronic and Becton Dickinson highlighted as Zacks Bull and Bear of the Day

NTGR : 32.67 (-3.09%)
BSX : 41.17 (-3.56%)
BDX : 248.31 (-2.69%)
TDY : 302.68 (-1.67%)
MDT : 106.05 (-1.65%)
FDA Resets PAD Guidelines: The Road Ahead for Device Makers

On its advisory list, the FDA suggests that doctors should point out the risks and benefits of all available PAD treatment options to their patients.

BSX : 41.17 (-3.56%)
BDX : 248.31 (-2.69%)
MDT : 106.05 (-1.65%)
Cardiovascular Systems Set to Present LIBERTY 360 Outcome

This study outcome is expected to be a major stride forward in Cardiovascular Systems' (CSII) endeavor to offer treatment to patients of multi-level peripheral artery disease (PAD).

BSX : 41.17 (-3.56%)
BDX : 248.31 (-2.69%)
MDT : 106.05 (-1.65%)
CSII : 48.22 (-4.23%)
Biotech Brief: Global Cellulite Treatment Market Revenues Expanding at Impressive Rate

People with cellulite are not as happy as those without cellulite. That may seem to be self-evident, but now it is supported by studies. One such report, a study published by Surgical and Cosmetic Dermatology,...

BSX : 41.17 (-3.56%)
BAX : 85.03 (-2.50%)
MDT : 106.05 (-1.65%)
SOLY : 12.85 (-6.48%)
Boston Scientific Rides on New Products Amid Dull Pacer Sales

Within MedSurg, Boston Scientific (BSX) is on track for the year-end launch of Exalt-D Single-Use Duodenoscope, which is used in ERCP procedures.

BSX : 41.17 (-3.56%)
NUVA : 63.44 (-2.88%)
BAX : 85.03 (-2.50%)
MDT : 106.05 (-1.65%)
Top Analyst Reports: Amgen, Uber, Mondelez & More

Top Analyst Reports: Amgen, Uber, Mondelez & More

MDLZ : 53.63 (-1.61%)
BSX : 41.17 (-3.56%)
XOM : 67.49 (-2.99%)
CCI : 146.34 (+0.16%)
UBER : 33.43 (-1.68%)
AMGN : 199.08 (-2.13%)
Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced an agreement naming Boston Scientific Corporation (NYSE: BSX) the exclusive distributor...

BSX : 41.17 (-3.56%)
ELGX : 5.50 (+4.36%)
Look for Shares of Boston Scientifc to Potentially Pullback after Yesterday's 1.33% Rise

Boston Scientifc (NYSE:BSX) traded in a range yesterday that spanned from a low of $40.51 to a high of $42.82. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of...

BSX : 41.17 (-3.56%)
Boston Scientifc Rises 1.33% on Heavy Volume: Watch For Potential Pullback

Boston Scientifc (NYSE:BSX) traded in a range yesterday that spanned from a low of $40.51 to a high of $42.82. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of...

BSX : 41.17 (-3.56%)
Global Intracardiac Echocardiography Market Shows Promising Growth & Intelligence with Competitive Landscape 2019-2025

The study collated by researchers at Brandessenceresearch.biz, is a detailed sketch of the business sphere in terms of current and future trends driving the profit matrix. The report also indicates a...

BSX : 41.17 (-3.56%)
CM.TO : 100.03 (-1.55%)
MDT : 106.05 (-1.65%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
AIZ -4.33 , WELL -1.15 , SBAC +0.27 , CCI +0.23 , SO -0.77
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar